Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Roche Holding AG

Revenue

Price Targets

# of Analysts

Consensus Recommendation

EBITDA

EBIT

Free Cash Flow

FFO / Share

AFFO / Share

NAV / Share

Book Value / Share

CapEx

Estimates	Dec '23 (A)	Dec '24 (A)	Dec '25 (E)
Mean	CHF 59,501.63	CHF 60,767.36	CHF 61,576.55
Median	CHF 59,121.60	CHF 60,499.22	CHF 61,486.78
Actual	CHF 58,716.00	CHF 60,495.00	—
High	CHF 61,935.03	CHF 62,188.00	CHF 62,914.80
Low	CHF 58,403.10	CHF 59,995.63	CHF 60,547.00
Standard Deviation	CHF 1,080.81	CHF 693.57	CHF 533.95
# of Estimates	14	16	14